Abstract
N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Letters in Organic Chemistry
Title:Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes
Volume: 12 Issue: 2
Author(s): Atukuri Dorababu, Ravindra R. Kamble, H. C. Devarajegowda and Gangadhar Y. Meti
Affiliation:
Keywords: Sydnone, triazole, terazole, formylation, iminium cation, Vilsmeir-Haack reaction.
Abstract: N-Substituted tetrazole was attempted to formylate which led to the formation of a novel triazene by opening of tetrazole ring via unusual Vilsmeir-Haack reaction. The formed product was proved by spectral analyses and X-Ray diffraction studies.
Export Options
About this article
Cite this article as:
Dorababu Atukuri, R. Kamble Ravindra, Devarajegowda H. C. and Y. Meti Gangadhar, Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes, Letters in Organic Chemistry 2015; 12 (2) . https://dx.doi.org/10.2174/157017861202150213102528
DOI https://dx.doi.org/10.2174/157017861202150213102528 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation
Recent Patents on Anti-Infective Drug Discovery Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Structure and Ligand-based Design of P-glycoprotein Inhibitors: A Historical Perspective
Current Pharmaceutical Design The MYC Oncogene as a Cancer Drug Target
Current Cancer Drug Targets The Mechanism in Gastric Cancer Chemoprevention by Allicin
Anti-Cancer Agents in Medicinal Chemistry Self-Adjuvanting Lipopeptide Vaccines
Current Medicinal Chemistry Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Current Drug Therapy Potentials of Hydrogels in Cancer Therapy
Current Cancer Therapy Reviews Nanotechnology, A Tool for Diagnostics and Treatment of Cancer
Current Topics in Medicinal Chemistry Gemcitabine: A Critical Nucleoside for Cancer Therapy
Current Medicinal Chemistry BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets Electrochemical Study of Ellipticine Interaction with Single and Double Stranded Oligonucleotides
Anti-Cancer Agents in Medicinal Chemistry Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Therapeutic Potential of Photochemically Active Metal Complexes based on Interaction with Enzymes
Current Topics in Medicinal Chemistry The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine Challenging the Current Approaches to Multiple Myeloma-Related Bone Disease: From Bisphosphonates to Target Therapy
Current Cancer Drug Targets